The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control

Molecular Survey on Vector-Borne Pathogens in Alpine Wild Carnivorans

(2020) Elena Battisti et al.   Frontiers in Veterinary Science

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine

(2020) Susan Hills et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial

(2019) Yan Li et al.   LANCET INFECTIOUS DISEASES

Japanese encephalitis — the prospects for new treatments

(2018) Lance Turtle et al.   Nature Reviews Neurology

Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study

(2018) Babasaheb V. Tandale et al.   Journal of Infection and Public Health

Vaccine confidence plummets in the Philippines following dengue vaccine scare: why it matters to pandemic preparedness

(2018) Heidi J Larson et al.   Human Vaccines & Immunotherapeutics

Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms

(2017) Mick N. Mulders et al.   JOURNAL OF INFECTIOUS DISEASES

Autochthonous Japanese Encephalitis with Yellow Fever Coinfection in Africa

(2017) Etienne Simon-Loriere et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of the live attenuated Japanese Encephalitis vaccine SA 14–14–2 in children: A review of safety and tolerability studies

(2017) Amy Sarah Ginsburg et al.   Human Vaccines & Immunotherapeutics

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016

(2017) James D. Heffelfinger et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy

(2017) P Ravanini et al.   Eurosurveillance

Differential Diagnosis of Japanese Encephalitis Virus Infections with the Inbios JE Detect ™ and DEN Detect ™ MAC-ELISA Kits

(2016) Barbara W. Johnson et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Lesson learned from investigating cluster adverse event following immunization in mass campaign of Japanese Encephalitis vaccine in India

(2016) A.K. Singh et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A large outbreak of Japanese encephalitis predominantly among adults in northern region of West Bengal, India

(2016) Yogesh K. Gurav et al.   JOURNAL OF MEDICAL VIROLOGY

Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013

(2014) Manoj V. Murhekar et al.   JOURNAL OF INFECTION

Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2

(2014) Emmanuel Feroldi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012

(2014) Yu Liu et al.   VACCINE

Lot-to-lot consistency of live attenuated SA 14-14-2 Japanese encephalitis vaccine manufactured in a good manufacturing practice facility and non-inferiority with respect to an earlier product

(2014) K. Zaman et al.   VACCINE

Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka

(2014) Pushpa Ranjan Wijesinghe et al.   VACCINE

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012

(2014) Heidi J. Larson et al.   VACCINE

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

(2014) Dong Soo Kim et al.   Human Vaccines & Immunotherapeutics

Tracking the global spread of vaccine sentiments: The global response to Japan's suspension of its HPV vaccine recommendation

(2014) Heidi J Larson et al.   Human Vaccines & Immunotherapeutics

WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012

(2013) Dennis W. Trent et al.   BIOLOGICALS

First indigenous transmission of Japanese Encephalitis in urban areas of National Capital Territory of Delhi, India

(2013) Roop Kumari et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241]

(2013) John C. Victor et al.   VACCINE

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

(2012) Elina O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports

(2011) Na Jia et al.   BMC INFECTIOUS DISEASES

Estimated global incidence of Japanese encephalitis:

(2011) Grant Campbell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Genotype V Japanese Encephalitis Virus Is Emerging

(2011) Ming-Hua Li et al.   PLoS Neglected Tropical Diseases

Comparing the Effectiveness of Shared versus Private Latrines in Preventing Trachoma in Rural Tanzania

(2010) Maggie A. Montgomery et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Field evaluation of commercial Immunoglobulin M antibody capture ELISA diagnostic tests for the detection of Japanese encephalitis virus infection among encephalitis patients in Nepal

(2010) Asheena Khalakdina et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Clinical features, diagnosis, and management of enterovirus 71

(2010) Mong How Ooi et al.   LANCET NEUROLOGY

Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples

(2010) Penny Lewthwaite et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance

(2009) Susan Hills et al.   BMC INFECTIOUS DISEASES

Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis

(2009) Rashmi Kumar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

(2008) Salvacion Gatchalian et al.   VACCINE

Potential for the Emergence of Japanese Encephalitis Virus in California

(2008) R.J. Nett et al.   VECTOR-BORNE AND ZOONOTIC DISEASES